Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergic contact dermatitis to topical fluorouracil

D K Goette, R B Odom

    Archives of Dermatology
    |August 1, 1977
    PubMed
    Summary

    Allergic contact dermatitis can occur with topical fluorouracil treatment. Severe itching and rash at the application site may indicate this reaction, prompting further investigation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Safety of itraconazole pulse therapy for onychomycosis. An update.

    Postgraduate medicine·1999
    Same author

    Topical metronidazole maintains remissions of rosacea.

    Archives of dermatology·1998
    Same author

    Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.

    Journal of the American Academy of Dermatology·1998
    Same author

    Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.

    Journal of the American Academy of Dermatology·1998
    Same author

    Mycosis fungoides with onset before 20 years of age.

    Journal of the American Academy of Dermatology·1997
    Same author

    Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis.

    Cutis·1997

    Area of Science:

    • Dermatology
    • Pharmacology

    Background:

    • Topical fluorouracil is a common treatment for actinic keratoses.
    • Adverse reactions to topical medications can impact patient compliance and outcomes.

    Purpose of the Study:

    • To determine the incidence of allergic contact dermatitis (ACD) from topical fluorouracil.
    • To identify clinical characteristics associated with fluorouracil-induced ACD.

    Main Methods:

    • Prospective and retrospective study design.
    • Intracutaneous and epicutaneous skin testing with varying fluorouracil concentrations.
    • Inclusion of patients initiating treatment (Group A) and those with prior exposure (Group B).

    Main Results:

    • Six patients in Group B (prior fluorouracil exposure) developed ACD.
    • The primary clinical manifestation was a severe, pruritic eruption at the application site.
    • No incidence reported in Group A (new treatment).

    Conclusions:

    • ACD is a potential adverse reaction to topical fluorouracil.
    • Severe pruritus and eczematous responses warrant suspicion of ACD.
    • Consider ACD in patients presenting with these symptoms during or after fluorouracil therapy.

    Related Experiment Videos